Through five years of follow-up, no cases of valve thrombosis or structural valve deterioration were observed with a bioprosthesis using the new Resilia tissue technology.
At centers of excellence, contemporary outcomes of surgical aortic valve replacement have improved to the point that STS risk score is no longer a useful predictor, a Cleveland Clinic study concludes.
Our experts outline their vision of ideal changes to the National Coverage Determination for programs performing transcatheter aortic valve replacement. A CMS decision is due in June 2019.
The latest PARTNER 2A analysis finds that worsening RV function is much more common after SAVR than TAVR. And it predicts greater risk for poor outcomes regardless of procedure type.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Long-term survival after surgical aortic valve replacement is lower when it’s for aortic stenosis that’s due to prior chest radiotherapy, a new study shows. But it’s too soon to assume TAVR is a panacea.
The transcatheter approach to aortic valve replacement in intermediate-risk patients appears to curb the risk of these potentially deadly effects, new subanalyses presented at ACC.17 show.
Surgery at a high-volume center boosts long-term survival, even in patients with minimal or no symptoms and preserved LVEF. So finds a large new analysis with implications for treatment guidelines.
As 77 million baby boomers retire, the numbers of patients seeking treatment for aortic valve disease will increase – and Cleveland Clinic has the vast experience necessary to perform complex valve surgery